Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Karyopharm Therapeut (KPTI)

Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 93,499
  • Shares Outstanding, K 124,616
  • Annual Sales, $ 146,030 K
  • Annual Income, $ -143,100 K
  • 60-Month Beta 0.20
  • Price/Sales 0.65
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade KPTI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.18
  • Most Recent Earnings $-0.20 on 08/06/24
  • Next Earnings Date 11/07/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 57.38%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 975.70% on 12/21/23
  • IV Low 0.00% on 09/18/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 100
  • Volume Avg (30-Day) 106
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 16,979
  • Open Int (30-Day) 16,688

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.26
  • Number of Estimates 4
  • High Estimate -0.15
  • Low Estimate -0.34
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +13.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6920 +6.43%
on 09/05/24
0.8551 -13.87%
on 08/26/24
-0.0818 (-10.00%)
since 08/16/24
3-Month
0.6920 +6.43%
on 09/05/24
1.1600 -36.51%
on 06/24/24
-0.1935 (-20.81%)
since 06/18/24
52-Week
0.6174 +19.29%
on 12/11/23
1.9500 -62.23%
on 02/06/24
-0.4035 (-35.39%)
since 09/18/23

Most Recent Stories

More News
Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript

KPTI earnings call for the period ending June 30, 2024.

KPTI : 0.7365 (-1.84%)
Karyopharm Therapeutics: Q2 Earnings Snapshot

Karyopharm Therapeutics: Q2 Earnings Snapshot

KPTI : 0.7365 (-1.84%)
Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript

KPTI earnings call for the period ending March 31, 2024.

KPTI : 0.7365 (-1.84%)
Karyopharm Therapeutics: Q1 Earnings Snapshot

Karyopharm Therapeutics: Q1 Earnings Snapshot

KPTI : 0.7365 (-1.84%)
Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript

KPTI earnings call for the period ending December 31, 2023.

KPTI : 0.7365 (-1.84%)
Karyopharm Therapeutics: Q4 Earnings Snapshot

Karyopharm Therapeutics: Q4 Earnings Snapshot

KPTI : 0.7365 (-1.84%)
Karyopharm Therapeutics (KPTI) Q3 2023 Earnings Call Transcript

KPTI earnings call for the period ending September 30, 2023.

KPTI : 0.7365 (-1.84%)
Karyopharm Therapeutics: Q3 Earnings Snapshot

Karyopharm Therapeutics: Q3 Earnings Snapshot

KPTI : 0.7365 (-1.84%)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

KPTI : 0.7365 (-1.84%)
Karyopharm to Present Selinexor Data at the 2023 International Myeloma Society Annual Meeting and European Society of Gynaecological Oncology 2023 Annual Meetings

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

KPTI : 0.7365 (-1.84%)

Business Summary

Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics, Inc. is based in United States.

See More

Key Turning Points

3rd Resistance Point 0.8021
2nd Resistance Point 0.7917
1st Resistance Point 0.7710
Last Price 0.7365
1st Support Level 0.7399
2nd Support Level 0.7295
3rd Support Level 0.7088

See More

52-Week High 1.9500
Fibonacci 61.8% 1.4409
Fibonacci 50% 1.2837
Fibonacci 38.2% 1.1265
Last Price 0.7365
52-Week Low 0.6174

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar